![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, May 25, 2011 3:09:57 PM
The Gen1 worms will need to be made homozygous in order to be able to breed production animals for "Monster Silk".
Meanwhile work will continue on using the zinc fingers to made the necessary changes (deletion of silkworm silk protein genes) to allow the production of pure spider silk. Once that work has been done then those worms will need to be made homozygous. (Each time an animal has genetic modifications done, it needs to be made homozygous.)
I am *guessing* that they are probably starting from "scratch" with the zinc finger work (i.e.: using worms not previously modified with the piggyBac transposon). There are a number of reasons why that would be far preferable:
1) all the added genes would be in exact locations rather than the random ones done by the piggyBac
2) because the piggyBac would not have been involved, no royalties would be owing to ND on ZF modified worms (barring any additional agreements with ND that we haven't been informed of).
3) there would be no non-functional genes remaining in odd places as artifacts from the piggyBac process.
One possibility is that, in order to get a pure spider silk product on the market ASAP, the Gen1 might be modifed using ZFs merely to delete the silkworm silk protein gene(s), and then those animals later replaced by a superior worm produced by using zinc fingers only. I don't think that would save much time at all, nor much money but that depends on the pricing of zinc fingers.
I would be very surprised if the zinc finger work was not being done on worms not previously modified with the piggyBac.
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM